Aline Navega Biz

Population Health, School of Medicine and Population Health

Research Fellow in Decision Modelling

a.navega-biz@sheffield.ac.uk
+44 114 222 6300

Regent Court (ScHARR)

Full contact details

Aline Navega Biz
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
Sheffield
S1 4DA

Profile: I joined ScHARR (HEDS) as a Research Associate in July 2018. In my previous role, I worked as a Research Associate at the Health Technology Assessment Unit of the National Institute of Cardiology in Brazil.

Research interests

Economic evaluation of technologies in Health
Cost-effectiveness modelling
Budget impact analyses

Current projects

I currently work on SCHARR-TAG

Publications

Show: Featured publications All publications

Featured publications

Journal articles

Oliveira IAGD, Caetano R, Steffen RE & Biz AN (2019) A systematic review of economic evaluations of the use of memantine alone or combined with donepezil for moderate to severe Alzheimer’s disease. Revista Brasileira de Geriatria e Gerontologia, 22(4). View this article in WRRO
Pinto M, Bardach A, Palacios A, Biz A, Alcaraz A, Rodriguez B, Augustovski F & Pichon-Riviere A (2019) Burden of smoking in Brazil and potential benefit of increasing taxes on cigarettes for the economy and for reducing morbidity and mortality. Cadernos de Saúde Pública, 35(8). View this article in WRRO

All publications

Journal articles

Tappenden P, Navega Biz A, Hernández Alava M, Sasso A, Sutton L, Ennis K, Elliott R & Wildman M (2023) A model-based economic analysis of the CFHealthHub intervention to support adherence to inhaled medications for people with cystic fibrosis in the UK. International Journal of Technology Assessment in Health Care, 39(1).
Ivama-Brummell AM, Pinilla-Dominguez P & Biz AN (2022) The regulatory, evaluation, pricing and reimbursement pathway for medicines in the UK: combining innovation and access. Brazilian Journal of Hospital Pharmacy and Health Services, 13(2).
Santos M, Monteiro AL, Biz AN, Guerra A, Cramer H, Canuto V, Cruz L, Pinto M, Viegas M, Fernandes R & Zimmermann I (2022) Guidelines for utility measurement for economic analysis: The Brazilian policy. Value in Health Regional Issues, 31, 67-73.
Oliveira IAGD, Caetano R, Steffen RE & Biz AN (2019) A systematic review of economic evaluations of the use of memantine alone or combined with donepezil for moderate to severe Alzheimer’s disease. Revista Brasileira de Geriatria e Gerontologia, 22(4). View this article in WRRO
Pinto M, Bardach A, Palacios A, Biz A, Alcaraz A, Rodriguez B, Augustovski F & Pichon-Riviere A (2019) Burden of smoking in Brazil and potential benefit of increasing taxes on cigarettes for the economy and for reducing morbidity and mortality. Cadernos de Saúde Pública, 35(8). View this article in WRRO
Caetano R, Silva RMD, Pedro ÉM, Oliveira IAGD, Biz AN & Santana P (2017) Incorporação de novos medicamentos pela Comissão Nacional de Incorporação de Tecnologias do SUS, 2012 a junho de 2016 / Incorporation of new medicines by the National Commission for Incorporation of Technologies, 2012 to June 2016. Ciência & Saúde Coletiva, 22(8), 2513-2525. View this article in WRRO
Caetano R, Biz AN, Schluckebier LF, Silva RMD, Braga JU & Bastos CRG (2016) Custo-efetividade do uso da tomografia de emissão de pósitrons na detecção de recorrência do câncer diferenciado de tireoide. Physis: Revista de Saúde Coletiva, 26(1), 331-356. View this article in WRRO
Biz AN & Caetano R (2015) Budget impact from the incorporation of positron emission tomography – computed tomography for staging lung cancers. Revista de Saúde Pública, 49. View this article in WRRO
Lampreia S, Costa R, Biz A, Silva VLDCE, Figueiredo VDC, Iglesias R, Machado DC & Waltenberg F (2015) Tabagismo no Brasil : estimação das elasticidades preço e renda na participação e na demanda por cigarros industrializados. Pesquisa e Planejamento Econômico (PPE), 45(2), 245-270. View this article in WRRO
Caetano R, Schluckebier LF, Bastos CRG, Silva RMD, Carneiro MP, Silva JWED & Biz AN (2014) Análise dos custos do procedimento PET-TC com 18 F-FDG na perspectiva do SUS provedor: estudo em uma unidade pública de saúde do Rio de Janeiro, Brasil. Cadernos de Saúde Pública, 30(2), 379-392. View this article in WRRO
Oliveira IAGD, Caetano R, Steffen RE & Biz AN () Cost-utility analysis of memantine in Alzheimer’s Disease in Brazil. Research, Society and Development, 11(11), e556111133846-e556111133846.
Wildman MJ, O’Cathain A, Hind D, Maguire C, Arden MA, Hutchings M, Bradley J, Walters SJ, Whelan P, Ainsworth J , Tappenden P et al () An intervention to support adherence to inhaled medication in adults with cystic fibrosis: the ACtiF research programme including RCT. Programme Grants for Applied Research, 9(11), 1-146.